The third session of the series held by the Egyptian Drug Authority (EDA) as part of the fourth edition of the Africa Health Exhibition and Conference witnessed discussions on regulatory developments in Egypt related to the localization of the medical device industry.
During the session, the Egyptian Drug Authority's efforts in this area were highlighted, emphasizing how these changes contribute to promoting economic growth and improving the quality of available pharmaceutical products.
Emphasis was also placed on the latest regulatory updates issued by the Egyptian Drug Authority (EDA), which directly aim to encourage and localize the medical device industry domestically. The specific measures taken to simplify approval processes and facilitate local production were highlighted, demonstrating how these changes translate into real opportunities for manufacturers. It was affirmed that these updates represent a qualitative enhancement in promoting self-sufficiency and decreasing import dependence.
Discussions delved into analyzing the tangible impact of these regulatory updates on the growth and development of the local medical device industry in Egypt, and how regulations contribute to creating a more attractive environment for local and foreign investment in this vital sector.
Attention was drawn to Egypt's efforts in aligning its regulatory framework for medical devices with international standards and best global practices, with a particular focus on the International Medical Device Regulators Forum (IMDRF). Also highlighted were the Egyptian Drug Authority's efforts in promoting localization and supporting innovation by providing a supportive regulatory environment, simplifying procedures, and guiding manufacturers towards compliance with global standards.
Finally, the critical role of Research and Development (R&D) as a key element for leveraging opportunities in the region's medical device industry was noted, alongside medical device software and the strategic utilization of artificial intelligence